Topical antibiotics for the treatment of acne vulgaris: A critical evaluation of the literature on their clinical benefit and comparative efficacy

References

• Mulrow C D. The medical review article: state of the science. Ann Intern Med 1987; 106: 485–88
   PubMed Web of Science ®Google Scholar
• Jenicek M. Meta-analysis in medicine. Where we are and where we want to go. J Clin Epidemiol 1989; 42: 35–44
   PubMed Web of Science ®Google Scholar
• L'Abbé K A, Detsky A S, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224–33
   PubMed Web of Science ®Google Scholar
• Pocock S J. Clinical trials. A practical approach. John Wiley & Sons, Chichester 1983
   Google Scholar
• Cunliffe W J. ch 6 and 16. Acne. Martin Dunitz Ltd, London 1989
   Google Scholar
• Allen B S, Smith J G. Various parameters for grading acne vulgaris. Arch Dermatol 1982; 118: 23–7
   PubMed Web of Science ®Google Scholar
• Burke B M, Cunliffe W J. The assessment of acne vulgaris -the Leeds technique. Br J Dermatol 1984; 111: 83–92
   PubMed Web of Science ®Google Scholar
• Cook C H, Centner R L, Michaels S E. An acne grading method using photographic standards. Arch Dermatol 1979; 115: 571–5
   PubMed Web of Science ®Google Scholar
• Pillsbury D M. A manual of dermatology. WB Saunders Co, Philadelphia 1971; 173
   Google Scholar
• Plewig G, Kligman A M. Acne. Morphogenesis and treatment. Springer-Verlag, New York 1975; 162–3
   Google Scholar
• Kligman A M. An overview of acne. J Invest Dermatol 1974; 62: 268–87
   PubMed Web of Science ®Google Scholar
• Aguilar A F, Bran E L, Gamboa J DP, et al. Multicentric comparative study of the efficacy and tolerance of clindamycin phosphate 1% topical solution and tetracycline topical solution for the treatment of acne vulgaris. Curr Ther Res 1988; 43: 21–6
   Google Scholar
• Anderson R L, Cook C H, Smith D E. The effect of oral and topical tetracycline on acne severity and on surface lipid composition. J Invest Dermatol 1976; 66: 172–7
   PubMed Web of Science ®Google Scholar
• Becker L E, Bergstresser P R, Whiting D A, et al. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study. Arch Dermatol 1981; 117: 482–5
   PubMed Web of Science ®Google Scholar
• Bernstein J E, Shalita A R. Topically applied erythromycin in inflammatory acne vulgaris. J Am Acad Dermatol 1980; 2: 318–21
   Google Scholar
• Blaney D J, Cook C H. Topical use of tetracycline in the treatment of acne. Arch Dermatol 1976; 112: 971–3
   PubMedGoogle Scholar
• Borglund E, Hagermark O, Nord C E. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris. Scand J Infect Dis Suppl 1984; 43: 76–81
   PubMedGoogle Scholar
• Braathen L R. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris. Scand J Infect Dis Suppl 1984; 43: 71–5
   Google Scholar
• Bran E L, Robledo Aguilar A. Estudio de la efectividad terapéutica del phoshato de clindamycina (solución 1 por 100) comparada con tetracyclina (solución) administradas topicamente en el tratamiento del acne vulgaris. Med Cutan Ibero Lat Am 1986; 14: 433–42
   Google Scholar
• Budden M G. Topical and oral tetracycline in the treatment of acne vulgaris. Practitioner 1988; 232: 669–74
   Google Scholar
• Burke B, Eady E A, Cunliffe W J. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 1983; 108: 199–204
   PubMed Web of Science ®Google Scholar
• Chalker D K, Shalita A, Smith J G, Swann R W. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9: 933–6
   PubMed Web of Science ®Google Scholar
• Dobson R L, Belknap B S. Topical erythromycin solution in acne. Results of a multi-clinic trial. J Am Acad Dermatol 1980; 3: 478–82
   PubMed Web of Science ®Google Scholar
• Ellis C N, Gammon W R, Stone D Z, Heezen-Wehner J L. A comparison of Cleocin-T solution, Cleocin-T gel and placebo in the treatment of acne vulgaris. Cutis 1988; 42: 245–7
   PubMedGoogle Scholar
• Exner J H, Comite H, Dahod S, Pochi P E. Topical erythromycin/zinc: effect on acne and sebum excretion. Curr Ther Res 1983; 34: 762–7
   Google Scholar
• Feucht C L, Allen B S, Chalker D K, Smith J G. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980; 3: 483–91
   PubMed Web of Science ®Google Scholar
• Frank S B. Topical treatment of acne with a tetracycline preparation: results of a multi-group study. Cutis 1976; 17: 539–45
   PubMedGoogle Scholar
• Freitag G, Kulenkamp D, Lazar R, et al. Erfahrungsbericht fiber die klinische pruning eines neuen flussigen erythromycin-haltigen externums zur behandlung der akne. Z Hautkr 1983; 58: 423–7
   Google Scholar
• Fulton J E, Pablo G. Topical antibacterial therapy for acne. Study of the family of erythromycins. Arch Dermatol 1974; 110: 83–6
   PubMedGoogle Scholar
• Goltz R W, Coryell G M, Schnieders J R, et al. A comparison of Cleocin T 1% solution and Cleocin T 1% lotion in the treatment of acne vulgaris. Cutis 1985; 36: 265–8
   PubMedGoogle Scholar
• Gratton D, Raymond G P, Guertin-Larochelle S, et al. Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial. J Am Acad Dermatol 1982; 7: 50–3
   PubMed Web of Science ®Google Scholar
• Guertin-Larochelle S, Raymond G P, Gratton D, et al. Étude comparative a double insu du phosphate de clindamycine topique, du chlorhydrate de tétracycline per os et d'un placebo dans la traitement de l'acné vulgaire modérée à sévère. Union Med Can 1982; 111: 559–62
   Google Scholar
• Guin J D. Topical clindamycin: a double-blind study comparing clindamycin phosphate with clindamycin hydrochloride. Int J Dermatol 1979; 18: 164–6
   PubMed Web of Science ®Google Scholar
• Guin J D. Treatment of acne vulgaris with topical clindamycin phosphate: a double blind study. Int J Dermatol 1981; 20: 286–8
   PubMed Web of Science ®Google Scholar
• Günther I. Behandlung der akne papulopustulosa mit erythromycinlosungen. Forschr Med 1986; 104: 887–9
   Google Scholar
• Hellgren L, Vincent J. Topical erythromycin for acne vulgaris. Dermatologica 1980; 161: 409–14
   Google Scholar
• Hellgren L, Vincent J. Entzündungshemmung bei akne vulgaris durch ein erythromycin-externum in alkoholischer losung. Dermatol Monatsschr 1983; 169: 702–5
   Google Scholar
• Hjorth N, Schmidt H, Thomsen K, et al. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double blind clinical study. Acta Derm Venereol (Stockh) 1984; 64: 354–7
   Google Scholar
• Jones E L, Crumley A F. Topical erythromycin vs blank vehicle in a multiclinic acne study. Arch Dermatol 1981; 117: 551–3
   PubMedGoogle Scholar
• Katsambas A, Towarky A A, Stratigos J. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris. Br J Dermatol 1987; 116: 387–91
   PubMed Web of Science ®Google Scholar
• Knutson D D, Swinyer L J, Smoot W H. Meclocycline subsalicylate. Topical antibiotic agent for the treatment of acne vulgaris. Cutis 1981; 27: 203–10
   Google Scholar
• Kuhlman D S, Callen J P. A comparison of clindamycin phosphate 1% topical lotion and placebo in the treatment of acne vulgaris. Cutis 1986; 38: 203–6
   PubMedGoogle Scholar
• Lesher J L, Chalker D K, Smith J G, et al. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris. J Am Acad Dermatol 1985; 12: 526–31
   PubMed Web of Science ®Google Scholar
• Leyden J L, McGinley K, Mills O H, et al. Topical antibiotics and topical antimicrobial agents in acne therapy. Acta Derm Venereol Suppl (Stockh) 1980; 89: 75–81
   Google Scholar
• Leyden J L, Shalita A R, Saatjian G D, et al. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. J Am Acad Dermatol 1987; 16: 882–7
   Google Scholar
• Llorca M A, Hernández-Gil A, Ramos M, et al. Erythromycin laurilsulfate in the topical treatment of acne vulgaris. Curr Ther Res 1982; 32: 14–20
   Google Scholar
• McKenzie M W, Beck D C, Popovich N G. Topical clindamycin formulations for the treatment of acne vulgaris. Arch Dermatol 1981; 117: 630–4
   PubMedGoogle Scholar
• Mills O H, Kligman A M, Stewart R. The clinical effectiveness of topical erythromycin in acne vulgaris. Cutis 1975; 15: 93–6
   Google Scholar
• Mills O H, Kligman A M. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol (Stockh) 1978; 58: 555–7
   PubMedGoogle Scholar
• Norris J FB, Hughes B R, Basey A J, . A comparison of the effectiveness of oral oxytetracycline, benzoyl peroxide gel and topical tetracycline in the treatment of acne. Acne and related disorders, R Marks, G Plewig, et al. Martin Dunitz Ltd, London 1989; 261–3
   Google Scholar
• Oumeish O Y, Hussein M A. Topical clindamycin in the treatment of acne vulgaris. Curr Ther Res 1980; 28: 381–6
   Google Scholar
• Padilla R S, McCabe J M, Becker L E. Topical tetracycline hydrochloride vs topical clindamycin phosphate in the treatment of acne. A comparative study. Int J Dermatol 1981; 20: 445–8
   PubMed Web of Science ®Google Scholar
• Panzer J D, Panzer J J. Topical clindamycin in acne: a preliminary study. Cutis 1979; 24: 118–19
   PubMedGoogle Scholar
• Parker F. A comparison of clindamycin 1 % solution versus clindamycin 1% gel in the treatment of acne vulgaris. Int J Dermatol 1987; 26: 121–2
   PubMedGoogle Scholar
• Perez M, Aspiolea F, De Moragas J M. Estudio comparative a doble ciego entre fosfato de clindamicina tópica y tetraciclina oral en el tratamiento del acné. MedCutan Ibero Lot Am 1987; 15: 173–7
   Google Scholar
• Perez-Lopez M, Moragas-Viñas J M. Nueva sal de eritromicina (A-137 o laurilsulfato de eritromicina) en el tratamiento tópico del acne. Med Cutan Ibero Lat Am 1982; 10: 151–8
   Google Scholar
• Petersen M J, Krusinski P A, Krueger G G. Evaluation of 1% clindamycin phosphate lotion in the treatment of acne: comparison with 1% clindamycin phosphate solution and lotion placebo. Curr Ther Res 1986; 40: 232–8
   Google Scholar
• Pfannschmidt N, Bauer R, Kreysel H W. Die topische kombinationbehandlung der akne mit erythromycin und tretinoin. Z Hautkr 1988; 63: 366–8
   PubMedGoogle Scholar
• Pochi P E, Bagatell F K, Ellis C N, et al. Erythromycin 2 percent gel in the treatment of acne vulgaris. Cutis 1988; 41: 132–6
   PubMed Web of Science ®Google Scholar
• Prince R A, Busch D A, Hepler C D, et al. Clinical trial of topical erythromycin in inflammatory acne. Drug Intell Clin Pharm 1981; 15: 372–6
   Google Scholar
• Rapaport M, Puhvel S M, Reisner R M. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris. Cutis 1982; 30: 122–35
   Google Scholar
• Resh W, Stoughton R B. Topically applied antibiotics in acne vulgaris. Arch Dermatol 1976; 112: 182–4
   PubMedGoogle Scholar
• Rietschel R L, Duncan S H. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983; 22: 41–3
   PubMed Web of Science ®Google Scholar
• Rivkin L, Rapaport M. Clinical evaluation of a new erythromycin solution for acne vulgaris. Cutis 1980; 25: 552–5
   Google Scholar
• Rozman T A, Klövekorn G, Kompa M. Doppelblinder gruppenvergleich von topischen meclocyclin, erythromycin und placebo in der behandlung der akne papulo-pustulosa. Z Hautkr 1984; 59: 1623–34
   Google Scholar
• Schmidt J B, Knobler R, Neumann R, et al. Externe erythromycintherapie bei akne. Z Hautkr 1983; 58: 1754–60
   Google Scholar
• Schmidt J B, Neumann R, Fanta D, et al. 1% clindamycin-phosphatlösung versus 5% benzoylperoxid-gel bei papulopustuloser akne. Z Hautkr 1988; 63: 374–6
   Google Scholar
• Schmidt J B, Thurner J, Poitscheck C, et al. Ein erythromycinhaltiges externum im klinischen test bei akne. Z Hautkr 1982; 57: 69–77
   Google Scholar
• Schneider W D. Behandlung der akne vulgaris mit clindamycin-phoshat in der dermatologischen praxis. Z Hautkr 1985; 60: 1599–608
   Google Scholar
• Schwanitz H J, Macher E. Interne versus externe tetrazy-klintherapie der akne. Z Hautkr 1984; 59: 1515–21
   Google Scholar
• Shalita A R, Smith E B, Bauer E. Topical erythromycin v clindamycin therapy for acne. A multicentre, double-blind comparison. Arch Dermatol 1984; 120: 351–5
   PubMedGoogle Scholar
• Smith J G, Chalker D K, Wehr R F. The effectiveness of topical and oral tetracycline for acne. South Med J 1976; 69: 695–7
   PubMed Web of Science ®Google Scholar
• Stoughton R B, Cornell R C, Gange R W, et al. Double-blind comparison of topical 1 % clindamycin phosphate (Cleocin-T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris. Cutis 1980; 26: 424–9
   PubMed Web of Science ®Google Scholar
• Stoughton R B, Resh W. Topical clindamycin in the control of acne vulgaris. Cutis 1976; 17: 551–4
   PubMedGoogle Scholar
• Strauss J S, Stranieri A M. Acne treatment with topical erythromycin and zinc; effect on Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984; 11: 86–9
   PubMed Web of Science ®Google Scholar
• Swinyer L J, Baker M D, Swinyer T A, et al. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. Br J Dermatol 1988; 119: 615–22
   PubMedGoogle Scholar
• Terpstra I J. Acne treatment with 4 percent erythromycin and 1.2 percent zinc acetate. Acne and related disorders, R Marks, G Plewig. Martin Dunitz Ltd, London 1989; 225–9
   Google Scholar
• Thomas D R, Raimer S, Smith E B. Comparison of topical erythromycin 1.5% solution versus topical clindamycin phosphate 1% solution in the treatment of acne vulgaris. Cutis 1982; 29: 624–32
   PubMedGoogle Scholar
• Thomsen R J, Stranieri A, Knutson D, et al. Topical clindamycin treatment of acne. Clinical, surface lipid composition and quantitative surface microbiology response. Arch Dermatol 1980; 116: 1031–4
   PubMedGoogle Scholar
• Tucker S B, Tausend R, Cochran R, et al. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 1984; 110: 487–92
   PubMedGoogle Scholar
• Wechsler H L, Kirk J, Slone J. Acne treated with a topical tetracycline preparation; results of a one-year multi-group study. Int J Dermatol 1978; 17: 237–42
   Google Scholar
• Marples R R, Kligman A M. Limitations of paired comparisons of topical drugs. Br J Dermatol 1973; 88: 61–7
   Google Scholar
• Smith E B. Effect of investigator bias on clinical trials. Arch Dermatol 1989; 125: 216–18
   PubMedGoogle Scholar